{"id":890123,"date":"2025-09-29T08:40:38","date_gmt":"2025-09-29T12:40:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/"},"modified":"2025-09-29T08:40:38","modified_gmt":"2025-09-29T12:40:38","slug":"revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/","title":{"rendered":"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis"},"content":{"rendered":"

<\/p>\n

Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis<\/b><\/p>\n

New software further strengthens Revvity\u2019s market-leading position in in vivo imaging while empowering scientists with faster, more reproducible insights<\/i><\/p>\n

WALTHAM, Mass.–(BUSINESS WIRE<\/a>)–
\nToday Revvity, Inc.<\/a> (NYSE: RVTY), announced the launch of its Living Image\u2122 Synergy AI multimodal analysis software<\/a> for in vivo imaging researchers. The solution provides a unified platform with AI capabilities for seamless data analysis across optical, microCT, ultrasound, and other modalities\u2014reducing data inconsistencies, streamlining workflows, increasing throughput, and enhancing reproducibility, all with the intention of accelerating scientific discovery.<\/p>\n

\n\u201cOur Living Image Synergy AI software marks a significant leap forward in preclinical imaging analysis,\u201d said Kevin Quick, VP of platforms at Revvity. \u201cTracking, monitoring, and visualizing biological processes and disease progression is central to understanding complex biology and evaluating potential therapeutics early in development. By unifying disparate analysis tools and integrating AI into existing workflows, Revvity\u2019s new solution is directed towards enabling earlier insights and more consistent analysis across modalities, and greater reproducibility across studies\u2014ultimately helping researchers move faster and with more confidence.\u201d<\/p>\n

\nThe Living Image Synergy AI software centralizes analysis with a goal of eliminating the need for separate tools and enabling seamless correlation of datasets. Revvity developed this unified approach to help researchers uncover biological insights that might otherwise remain hidden when using isolated systems.<\/p>\n

\nTo further streamline workflows, the software features intuitive co-registration tools and automated processes that reduce manual tasks and analysis time. Advanced AI algorithms automate image segmentation and region-of-interest (ROI) quantification\u2014traditionally labor-intensive and variable steps in imaging analysis. This helps support high-throughput analysis and allows researchers to more efficiently monitor disease progression and assess therapeutic efficacy with greater accuracy and statistical confidence.<\/p>\n

\nThe Living Image Synergy AI software will be unveiled at the WMIC conference in Anchorage, Alaska from September 29 \u2013 October 3, 2025.<\/p>\n

About Revvity
\n
<\/b>At Revvity, \u201cimpossible\u201d is inspiration, and \u201ccan\u2019t be done\u201d is a call to action. Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what\u2019s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.<\/p>\n

\nWith 2024 revenue of more than $2.7 billion and approximately 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 160 countries.<\/p>\n

\nStay updated by following our Newsroom<\/a>, LinkedIn<\/a>, X<\/a>, YouTube<\/a>, Facebook<\/a> and Instagram<\/a>.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250929431653\/en\/<\/a><\/span><\/p>\n

Investor Relations:
\n<\/b>
Steve Willoughby
\n
steve.willoughby@revvity.com<\/a><\/p>\n

Media Relations:
\n<\/b>
Chet Murray
\n
(781) 663-5719
\n
chet.murray@revvity.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America Alaska Massachusetts<\/p>\n

INDUSTRY KEYWORDS:<\/b> Software Biotechnology Pharmaceutical Health Artificial Intelligence Medical Devices Health Technology Technology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis New software further strengthens Revvity\u2019s market-leading position in in vivo imaging while empowering scientists with faster, more reproducible insights WALTHAM, Mass.–(BUSINESS WIRE)– Today Revvity, Inc. (NYSE: RVTY), announced the launch of its Living Image\u2122 Synergy AI multimodal analysis software for in vivo imaging researchers. The solution provides a unified platform with AI capabilities for seamless data analysis across optical, microCT, ultrasound, and other modalities\u2014reducing data inconsistencies, streamlining workflows, increasing throughput, and enhancing reproducibility, all with the intention of accelerating scientific discovery. \u201cOur Living Image Synergy AI software marks a significant leap forward in preclinical imaging analysis,\u201d said Kevin Quick, VP of platforms at Revvity. \u201cTracking, monitoring, and visualizing biological … <\/p>\n

Continue reading “Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-890123","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nRevvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis New software further strengthens Revvity\u2019s market-leading position in in vivo imaging while empowering scientists with faster, more reproducible insights WALTHAM, Mass.–(BUSINESS WIRE)– Today Revvity, Inc. (NYSE: RVTY), announced the launch of its Living Image\u2122 Synergy AI multimodal analysis software for in vivo imaging researchers. The solution provides a unified platform with AI capabilities for seamless data analysis across optical, microCT, ultrasound, and other modalities\u2014reducing data inconsistencies, streamlining workflows, increasing throughput, and enhancing reproducibility, all with the intention of accelerating scientific discovery. \u201cOur Living Image Synergy AI software marks a significant leap forward in preclinical imaging analysis,\u201d said Kevin Quick, VP of platforms at Revvity. \u201cTracking, monitoring, and visualizing biological … Continue reading "Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-29T12:40:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250929431653r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis\",\"datePublished\":\"2025-09-29T12:40:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\\\/\"},\"wordCount\":485,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250929431653r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\\\/\",\"name\":\"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250929431653r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-09-29T12:40:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250929431653r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250929431653r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/","og_locale":"en_US","og_type":"article","og_title":"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis - Market Newsdesk","og_description":"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis New software further strengthens Revvity\u2019s market-leading position in in vivo imaging while empowering scientists with faster, more reproducible insights WALTHAM, Mass.–(BUSINESS WIRE)– Today Revvity, Inc. (NYSE: RVTY), announced the launch of its Living Image\u2122 Synergy AI multimodal analysis software for in vivo imaging researchers. The solution provides a unified platform with AI capabilities for seamless data analysis across optical, microCT, ultrasound, and other modalities\u2014reducing data inconsistencies, streamlining workflows, increasing throughput, and enhancing reproducibility, all with the intention of accelerating scientific discovery. \u201cOur Living Image Synergy AI software marks a significant leap forward in preclinical imaging analysis,\u201d said Kevin Quick, VP of platforms at Revvity. \u201cTracking, monitoring, and visualizing biological … Continue reading \"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-29T12:40:38+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250929431653r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis","datePublished":"2025-09-29T12:40:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/"},"wordCount":485,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250929431653r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/","name":"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250929431653r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-09-29T12:40:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250929431653r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250929431653r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/revvity-unveils-new-ai-software-offering-to-transform-preclinical-imaging-analysis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/890123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=890123"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/890123\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=890123"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=890123"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=890123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}